← Eichor
Study identifier: NCT04313140 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Condition: Development of the Virtual Biopsy · Tumor Grade · Artificial Intelligence Algorithms  ·  Sponsor: Poitiers University Hospital

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Rémy GUILLEVIN, Pr  ·  05.49.44.45.42  ·  remy.guillevin@chu-poitiers.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU De PoitiersPoitiers, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04313140